Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Journey Medical Corporation stock (Journey Medical Corp)

Buy Journey Medical Corporation stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Journey Medical Corporation is a drug manufacturers - specialty & generic business based in the US. Journey Medical Corporation shares (DERM) are listed on the NASDAQ and all prices are listed in US Dollars. Journey Medical Corporation employs 41 staff and has a trailing 12-month revenue of around $80 million.

Our top picks for where to buy Journey Medical stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Journey Medical Corporation stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DERM. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Journey Medical Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Not rated yet
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
Stocks, ETFs, Cryptocurrency
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Journey Medical Corporation stock price (NASDAQ: DERM)

Use our graph to track the performance of DERM stocks over time.

Journey Medical Corporation shares at a glance

Information last updated 2024-07-14.
Latest market close$5.91
52-week range$1.60 - $8.11
50-day moving average $4.52
200-day moving average $4.33
Wall St. target price$9.17
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.17

Is it a good time to buy Journey Medical Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Journey Medical Corporation price performance over time

Historical closes compared with the close of $5.91 from 2024-07-16

1 week (2024-07-11) 4.05%
1 month (2024-06-18) 9.85%
3 months (2024-04-18) 65.08%
6 months (2024-01-18) 18.67%
1 year (2023-07-18) 219.46%
2 years (2022-07-18) 74.34%
3 years (2021-07-14) N/A
5 years (2019-07-14) N/A

Is Journey Medical Corporation stock undervalued or overvalued?

Valuing Journey Medical Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Journey Medical Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Journey Medical Corporation's EBITDA

Journey Medical Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.1 million.

The EBITDA is a measure of a Journey Medical Corporation's overall financial performance and is widely used to measure a its profitability.

To put Journey Medical Corporation's EBITDA into context you can compare it against that of similar companies.

Journey Medical Corporation financials

Revenue TTM $80 million
Gross profit TTM $42.9 million
Return on assets TTM 0.42%
Return on equity TTM -40.69%
Profit margin -5.2%
Book value $0.65
Market Capitalization $113.3 million

TTM: trailing 12 months

Journey Medical Corporation share dividends

We're not expecting Journey Medical Corporation to pay a dividend over the next 12 months.

You may also wish to consider:

Journey Medical Corporation share price volatility

Over the last 12 months, Journey Medical Corporation's shares have ranged in value from as little as $1.6 up to $8.11. A popular way to gauge a stock's volatility is its "beta".

DERM.US volatility(beta: 0.94)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Journey Medical Corporation's is 0.936. This would suggest that Journey Medical Corporation's shares are less volatile than average (for this exchange).

To put Journey Medical Corporation's beta into context you can compare it against those of similar companies.

Journey Medical Corporation overview

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. In addition, the company sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Frequently asked questions

What percentage of Journey Medical Corporation is owned by insiders or institutions?
Currently 31.987% of Journey Medical Corporation shares are held by insiders and 13.81% by institutions.
How many people work for Journey Medical Corporation?
Latest data suggests 41 work at Journey Medical Corporation.
When does the fiscal year end for Journey Medical Corporation?
Journey Medical Corporation's fiscal year ends in December.
Where is Journey Medical Corporation based?
Journey Medical Corporation's address is: 9237 East Via de Ventura Boulevard, Scottsdale, AZ, United States, 85258
What is Journey Medical Corporation's ISIN number?
Journey Medical Corporation's international securities identification number is: US48115J1097

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site